These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 12640282

  • 1. Updates on attention deficit hyperactivity disorder, child abuse and neglect, and sudden infant death syndrome.
    Daley KC.
    Curr Opin Pediatr; 2003 Apr; 15(2):216-25. PubMed ID: 12640282
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacotherapy of ADHD in adults.
    Wilens TE.
    CNS Spectr; 2008 May; 13(5 Suppl 8):11-3. PubMed ID: 18567133
    [No Abstract] [Full Text] [Related]

  • 3. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
    Ni HC, Shang CY, Gau SS, Lin YJ, Huang HC, Yang LK.
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Methylphenidate vs atomoxetine: personalized medicine in attention- deficit/hyperactivity disorder.
    Heinrich H, Studer P, Moll GH, Kratz O.
    JAMA Psychiatry; 2013 May; 70(5):545. PubMed ID: 23636880
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of adult ADHD and comorbid disorders.
    Young JL.
    CNS Spectr; 2006 Oct; 11(10 Suppl 11):10-2. PubMed ID: 17712918
    [No Abstract] [Full Text] [Related]

  • 12. [Without treatment the crash threatens].
    Einecke U.
    MMW Fortschr Med; 2009 Jan 29; 151(5):14-6. PubMed ID: 19391404
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
    Slatkoff J, Greenfield B.
    Expert Opin Investig Drugs; 2006 Jun 29; 15(6):649-67. PubMed ID: 16732717
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V, Bittsansky M, Ondrejka I, Dobrota D.
    Psychiatry Res; 2014 Apr 30; 222(1-2):75-83. PubMed ID: 24679996
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines].
    Lehmkuhl G.
    MMW Fortschr Med; 2007 May 21; 149 Suppl 2():10-3; quiz 14. PubMed ID: 17724960
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
    Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, Cziraky MJ, Strom BL.
    Pharmacoepidemiol Drug Saf; 2010 Sep 21; 19(9):934-41. PubMed ID: 20623519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.